Disease burden metrics and the innovations of leading pharmaceutical companies: a global and regional comparative study
Abstract Background The recent innovation activities of global top-tier pharmaceutical companies in accordance with global and regional health concerns were investigated in order to identify their innovations contributing to population health. Methods “Innovation activity” was defined as the number...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2020-09-01
|
| Series: | Globalization and Health |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s12992-020-00610-2 |